PT MERCK TBK 
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
More news
More news
| Managers | Title | Age | Since |
|---|---|---|---|
Evie Yulin
CEO | Chief Executive Officer | 57 | 11-01-25 |
Bambang Nurcahyo
DFI | Director of Finance/CFO | 54 | 09-04-01 |
| Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Mei Lin Tang
CHM | Chairman | 62 | 20-07-28 |
| Director/Board Member | 80 | 03-05-12 |
PT Merck Tbk is an Indonesia-based pharmaceutical company. Its business is classfied into three divisions: consumer health division, Merck Serono prescription division and chemical division. The consumer health division produces and manufactures over-the-counter (OTC) drugs; some of the major brands under this division are Sangobion, Neurobion, Becombion and Seven Seas. Its Merck Serono prescription division produces and manufactures ethical drugs; the products under this division are categorized into six lines: cardiovascular, metabolic, neuro, general, biotech Serono and oncology. Its chemical division is further classified into two groups: Merck Millipore, offering products and services for the life science industry, and performance materials, offering high technology performance chemicals for cosmetics and packaging, coating, pigment and security industries.
Sector
-
